Abstract
Proteinase-activated receptors (PARs), a family of four seven-transmembrane G protein-coupled receptors, act as targets for signalling by various proteolytic enzymes. PARs are characterized by a unique activation mechanism involving the proteolytic unmasking of a tethered ligand that stimulates the receptor. Given the emerging roles of these receptors in cancer as well as in disorders of the cardiovascular, musculoskeletal, gastrointestinal, respiratory and central nervous system, PARs have become attractive targets for the development of novel therapeutics. In this Review we summarize the mechanisms by which PARs modulate cell function and the roles they can have in physiology and diseases. Furthermore, we provide an overview of possible strategies for developing PAR antagonists.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Drug Delivery Systems / methods
-
Drug Delivery Systems / trends*
-
Guanidines / administration & dosage
-
Guanidines / chemistry
-
Guanidines / metabolism
-
Humans
-
Neoplasms / drug therapy
-
Neoplasms / enzymology
-
Neoplasms / metabolism
-
Oligopeptides / administration & dosage
-
Oligopeptides / chemistry
-
Oligopeptides / metabolism
-
Pharmaceutical Preparations / administration & dosage*
-
Pharmaceutical Preparations / chemistry
-
Pharmaceutical Preparations / metabolism*
-
Receptors, Proteinase-Activated / agonists
-
Receptors, Proteinase-Activated / antagonists & inhibitors
-
Receptors, Proteinase-Activated / metabolism*
Substances
-
Guanidines
-
N-cinnamoyl-4-fluorophenylalanyl-4-guanidinophenylalanyl-leucyl-arginyl-argininamide
-
Oligopeptides
-
Pharmaceutical Preparations
-
Receptors, Proteinase-Activated